Saturday, October 23, 2021

Govt to build infectious disease institute next year, says PM

He says the institute will be to prevent illness, infirmities and deaths caused by infectious diseases.

Other News

An infectious disease institute will be built in Bandar Enstek, Negeri Sembilan, in 2022 under the 12th Malaysia Plan (12MP), says Prime Minister Ismail Sabri Yaakob.

When tabling the 12MP at the Dewan Rakyat today, he said the institute would be aimed at the prevention of diseases, infirmities and deaths caused by infectious diseases.

“The government is also reviewing the effectiveness of the existing health system and health policies will be formulated to enhance preparedness to manage infectious diseases as well as health crises,” he said.

He said the National Vaccine Development Road Map is being finalised to ensure that Malaysia is capable of producing its own vaccines and as preparation for any future pandemics.

“In the Covid-19 pandemic situation, the people placed high hopes in the government and the government is looking at the best ways to ensure the well-being of the Malaysian family in various aspects especially in healthcare and providing quality residence.

“The government stays committed to strengthening the healthcare system to ensure the people are healthy and productive,” he said.

In this regard, he said the government has also identified proactive measures to improve hospital preparedness to achieve the ratio of 2.06 hospital beds for every thousand residents by 2025.

The government will also develop new health facilities in addition to the 12 hospitals being built nationwide, expected to be completed during the 12MP, he said.

“Health facilities and equipment including ICUs will be increased and in the effort to close the gap between urban and rural health facilities, the government will be building and upgrading health clinics throughout the country,” he said.

Follow us on Telegram for the latest updates: https://t.me/malaysianow

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles